GlaxoSmithKline Pharmaceuticals CFO Juby Chandy Resigns for Regional Promotion
GlaxoSmithKline Pharmaceuticals Limited announced CFO and Whole-Time Director Juby Chandy's resignation effective March 11, 2026, following his promotion to Finance Head for GSK's Asia Pacific region. The company filed the disclosure on March 16, 2026, in compliance with SEBI regulations, with Chandy expressing gratitude for his tenure and wishing the organization continued success.